Research Paper Volume 12, Issue 20 pp 20254—20267
Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy
Figure 5. External validation of four-cell-type model in GSE44295 and GSE84976 datasets. (A–C) The AUC curves in GSE44295 and GSE84976 datasets. (B, D) Kaplan-Meier survival analysis in GSE44295 and GSE84976 datasets, revealed that the low-risk groups have a significantly better survival than the patients in high-risk group.